Skip to main content
OpenTrials

Clinical trial condition

SMARCA4-deficient Primary CNS Malignant Tumors

Explore clinical trials studying SMARCA4-deficient Primary CNS Malignant Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

SMARCA4-deficient Primary CNS Malignant Tumors trial results

Active, Not Recruiting

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

NCT05407441

Conditions
Atypical Teratoid Rhabdoid Tumor, Chordoma, Epithelioid Sarcoma, +11 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions